BRIEF published on 04/02/2026 at 04:05, 1 month 6 days ago Aperçu des résultats financiers de MedMira Inc. pour le deuxième trimestre de l'exercice 2026 Perte Nette Résultats Financiers De MedMira Frais D'exploitation Partenariat McKesson Chiffre D'affaires Du Deuxième Trimestre De L'exercice 2026
BRIEF published on 04/02/2026 at 04:05, 1 month 6 days ago MedMira Inc. Q2 FY2026 Financial Results Overview Net Loss Operating Expenses MedMira Financial Results McKesson Partnership Q2 FY2026 Revenue
PRESS RELEASE published on 04/02/2026 at 04:00, 1 month 6 days ago MedMira Reports Second Quarter Results FY2025 MedMira Inc. reports partnership with McKesson, financial results and progress on new tests. The company aims to expand market reach and improve sales Financial Results Clinical Trials MedMira Inc. RVF Technology McKesson Partnership
BRIEF published on 12/31/2025 at 02:05, 4 months 8 days ago MedMira Reports First Quarter Results for FY2026 Health Canada MedMira Q1 Financials MiROQ Technology Reveal® TP
BRIEF published on 12/31/2025 at 02:05, 4 months 8 days ago MedMira publie ses résultats du premier trimestre de l'exercice 2026 MedMira Santé Canada Technologie MiROQ Reveal® TP Résultats Financiers Du T1
PRESS RELEASE published on 12/31/2025 at 02:00, 4 months 8 days ago MedMira Reports First Quarter Results FY2026 MedMira Inc. reports Health Canada approval for Reveal® TP (Syphilis) rapid test, progress in clinical trials, and financial results for Q1 FY2026 Financial Results Clinical Trials MedMira Inc. Health Canada Approval Reveal® TP
BRIEF published on 11/29/2025 at 03:05, 5 months 9 days ago MedMira Releases FY2025 Financial Performance Financial Results MedMira Diagnostic Tests FY2025 MiROQ Technology
BRIEF published on 11/29/2025 at 03:05, 5 months 9 days ago MedMira publie ses résultats financiers pour l'exercice 2025 Résultats Financiers MedMira Exercice 2025 Tests Diagnostiques Technologie MiROQ
PRESS RELEASE published on 11/29/2025 at 03:00, 5 months 9 days ago MedMira Reports FY2025 Fourth Quarter and Year End Financial Results MedMira Inc. reports on financial results for FY2025, including product launches, clinical trials, and commercial advancements. Details on revenue, profit, loss, and balance sheet highlights are provided Financial Results Clinical Trials MedMira Inc. Product Launches Commercial Advancements
BRIEF published on 08/26/2025 at 22:48, 8 months 12 days ago Santé Canada approuve le test rapide de dépistage de la syphilis de MedMira Syphilis MedMira Santé Canada Tests Rapides Maladie Infectieuse
Published on 05/08/2026 at 01:50, 5 hours 40 minutes ago Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 6 hours 45 minutes ago Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 7 hours 30 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 8 hours ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 8 hours 15 minutes ago BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/08/2026 at 06:45, 45 minutes ago Krones starts financial year with strong order intake and confirms financial targets for 2026
Published on 05/08/2026 at 06:40, 49 minutes ago Jungfraubahn Holding AG: Jungfrau Railway Group: After a subdued start to 2026, this trend is becoming more pronounced
Published on 05/08/2026 at 06:30, 1 hour ago Interroll Holding AG announces the acquisition of Royal Apollo Group
Published on 05/08/2026 at 06:30, 1 hour ago Lonza Delivers Strong Performance in Q1 2026 in Line with Expectations and Confirms Full-Year Outlook 2026
Published on 05/07/2026 at 19:15, 12 hours 15 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 12 hours 15 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 12 hours 24 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 12 hours 24 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 12 hours 30 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
